Menu

Blog

Archive for the ‘biotech/medical’ category: Page 1365

May 21, 2021

Music stored in DNA

Posted by in categories: biotech/medical, media & arts

Circa 2017


What is the best way to preserve music for future generations to enjoy? Store it in DNA, of course.

That is exactly what Twist Biosciences, which pioneers high-quality DNA synthesis, has facilitated in collaboration with the University of Washington and Microsoft. Two iconic performances – from the iconic Montreux Jazz Festival, one Deep Purple’s playing of Smoke on the Water, and Tutu by Miles Davis, have been ‘encoded onto DNA and read back with 100 percent accuracy.

Continue reading “Music stored in DNA” »

May 21, 2021

CRISPR Editing in Primates

Posted by in categories: bioengineering, biotech/medical, business, genetics

There’s some really interesting CRISPR news out today, and it’s likely to be a forerunner of much more news to come. A research team has demonstrated what looks like robust, long-lasting effects in a primate model after one injection of the CRISPR enzymatic machinery. There have been plenty of rodent reports on various forms of CRISPR, and there are some human trials underway, but these is the first primate numbers that I’m aware of.

The gene they chose to inactivate is PCSK9, which has been a hot topic in drug discovery for some years now. It’s a target validated by several converging lines of evidence from the human population (see the “History” section of that first link). People with overactive PCSK9 have high LDL lipoproteins and cholesterol, and people with mutations that make it inactive have extremely low LDL and seem to be protected from a lot of cardiovascular disease. There are several drugs and drug candidates out there targeting the protein, as well there might be.

It’s a good proof-of-concept, then, because we know exactly what the effects of turning down the expression of active PCSK9 should look like. It’s also got the major advantage of being mostly a liver target – as I’ve mentioned several times on the blog already, many therapies aimed at gene editing or RNA manipulation have a pharmacokinetic complication. The formulations used to get such agents intact into the body (and in a form that they can penetrate cells) tend to get combed out pretty thoroughly by the liver – which after all, is (among other things) in the business of policing the bloodstream for weird, unrecognized stuff that is then targeted for demolition by hepatocytes. Your entire bloodstream goes sluicing through the liver constantly; you’re not going to able to dodge it if your therapy is out there in the circulation. It happens to our small-molecule drugs all the time: hepatic “first pass” metabolism is almost always a factor to reckon with.

May 21, 2021

Breakthrough in plant protection: RNAi pesticides affect only one pest species

Posted by in categories: biotech/medical, food

The harmfulness of pesticides to beneficial organisms is one of the most serious concerns in agriculture. Therefore scientists are eagerly looking for new, more environmentally friendly and species-specific solutions. Researchers at the Estonian University of Life Sciences, Ghent and the University of Maastricht took a long step forward in this regard.

The detrimental impact of pesticides on non-target organisms is one of the most urgent concerns in current agriculture. Double-stranded RNAs (dsRNAs) represent the most species-specific class of pesticides to date, potentially allowing control of a target pest without effecting other species. The unprecedented target-specificity of dsRNA is due to its nucleotide sequence-specific mode of action that results in post-transcriptional gene silencing, or RNA interference (RNAi), in the target species. The development and field use of dsRNAs, via both the insertion of transgenes into the plant genome and the application of dsRNA sprays, is a rapidly growing area of research. Simultaneously, there exists the growing prospect of harnessing RNAi within integrated pest management schemes.

Using the pollen beetle (Brassicogethes aeneus) and its host crop oilseed rape (Brassica napus) as a model crop-pest system, a team of researchers collectively from Estonian University of Life Sciences, Ghent University and Maastricht University examined how RNAi efficacy depends on duration of dietary exposure to dsRNA. To this end, the authors applied dsRNA (specifically designed to induce RNAi in the pollen beetle) to oilseed rape flowers, and analyzed RNAi-induced mortality between insects chronically fed dsRNA and insects fed dsRNA for 3 days. Most notably, their data suggest that, with chronic dietary exposure to dsRNA, reduced dsRNA concentrations can be applied in order to achieve a similar effect compared to short-term (e.g. 3 days) exposure to higher concentrations. This observation has important implications for optimizing dsRNA spray approaches to managing crop pests.

May 20, 2021

Dr. Morten Scheibye-Knudsen — University of Copenhagen — Aging, DNA Repair, And Clinical Innovation

Posted by in categories: biotech/medical, life extension, robotics/AI

Aging, DNA Repair, And Clinical Innovation — Dr. Morten Scheibye-Knudsen — University of Copenhagen.


Dr. Morten Scheibye-Knudsen is an Associate Professor at the Department of Cellular and Molecular Medicine, and at the Center for Healthy Aging (CEHA), at the University of Copenhagen.

Continue reading “Dr. Morten Scheibye-Knudsen — University of Copenhagen — Aging, DNA Repair, And Clinical Innovation” »

May 20, 2021

Face masks effectively limit the probability of SARS-CoV-2 transmission

Posted by in categories: biotech/medical, particle physics

Do we need to revisit this? 🤔


Airborne transmission by droplets and aerosols is important for the spread of viruses. Face masks are a well-established preventive measure, but their effectiveness for mitigating SARS-CoV-2 transmission is still under debate. We show that variations in mask efficacy can be explained by different regimes of virus abundance and related to population-average infection probability and reproduction number. For SARS-CoV-2, the viral load of infectious individuals can vary by orders of magnitude. We find that most environments and contacts are under conditions of low virus abundance (virus-limited) where surgical masks are effective at preventing virus spread. More advanced masks and other protective equipment are required in potentially virus-rich indoor environments including medical centers and hospitals. Masks are particularly effective in combination with other preventive measures like ventilation and distancing.

Airborne transmission is one of the main pathways for the transmission of respiratory viruses, including the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (1). Wearing face masks has been widely advocated to mitigate transmission. Masks are thought to protect people in two ways: source control reducing the emission and spread of respiratory viruses through airborne droplets and aerosols, and wearer protection reducing the inhalation of airborne respiratory viruses.

Continue reading “Face masks effectively limit the probability of SARS-CoV-2 transmission” »

May 20, 2021

Aubrey de Grey: Breakthroughs in Longevity & The Anti-Aging Revolution

Posted by in categories: biotech/medical, life extension, wearables

Famed longevity pioneer Aubrey de Grey, Chief Science Officer of SENS Research Foundation, joins Geoffrey Woo, Founder and Chairman of Health Via Modern Nutrition Inc., for an enlightening conversation about advances in longevity, the investments and technologies that extend life, and the challenges and opportunities of a world in which people live longer. He walks us through his damage repair therapies with a focus on rejuvenation, prevention, and wearable technologies. Filmed on May 17, 2021. To continue the discussion with fellow Real Vision members on this interview, click here to visit the Exchange: https://rvtv.io/2T7nqZL

Key Learnings: Longevity escape velocity, which is a term de Grey coined, is the idea in which life expectancy is extended longer than the time that is passing, and he estimates a 50% chance that aging could be brought under medical control in as little as 15 years’ time. To learn more about SENS’ research and advancements, please visit their site here: https://www.sens.org/.

May 20, 2021

Infectious-disease scientists at Canada’s high-security lab collaborated with China

Posted by in categories: biotech/medical, military

Scientists working at Canada’s highest-security infectious-disease laboratory have been collaborating with Chinese military researchers to study and conduct experiments on deadly pathogens.

Seven scientists in the special pathogens unit at the National Microbiology Laboratory (NML) in Winnipeg and Chinese military researchers have conducted experiments and co-authored six studies on infectious diseases such as Ebola, Lassa fever and Rift Valley fever. The publication dates of the studies range from early 2016 to early 2020.

The Globe and Mail has also learned that one of the Chinese researchers, Feihu Yan, from the People’s Liberation Army’s (PLA) Academy of Military Medical Sciences, worked for a period of time at the Winnipeg lab, a Level 4 facility equipped to handle some of the world’s deadliest diseases. This researcher is credited as a co-author on all six of the papers. However, on two of them, he is listed as being affiliated with both the Winnipeg lab and the military medical academy.

May 20, 2021

New Coronavirus Detected In Patients At Malaysian Hospital; The Source May Be Dogs

Posted by in category: biotech/medical

A previously unknown novel coronavirus capable of infecting people has been discovered in Borneo, says a team of researchers from Duke University.

May 20, 2021

No, Science Clearly Shows That COVID-19 Wasn’t Leaked From A Wuhan Lab

Posted by in categories: biotech/medical, science

It occurred naturally, and scientists know this for certain.

May 20, 2021

Dr Jamie L. Wells, MD — Director, Research Science Inst — Pediatrician, Medical Innovator, Educator

Posted by in categories: biotech/medical, bitcoin, business, education, health, policy, robotics/AI, science

Pediatrician, Medical Innovator, Educator — Dr. Jamie Wells, MD, FAAP — Director, Research Science Institute (RSI), Center for Excellence in Education, Massachusetts Institute of Technology (MIT) — Professor, Drexel University School of Biomedical Engineering, Science and Health Systems.


Dr. Jamie L. Wells, MD, FAAP, is an Adjunct Professor at Drexel University’s School of Biomedical Engineering, Science and Health Systems, where she has been involved in helping to spearhead the nation’s first-degree program focused on pediatric engineering, innovation, and medical advancement.

Continue reading “Dr Jamie L. Wells, MD — Director, Research Science Inst — Pediatrician, Medical Innovator, Educator” »